| 标题 |
Abstract GS2-01: GS2-01 Trastuzumab deruxtecan vs physician’s choice in patients with HER2+ unresectable and/or metastatic breast cancer previously treated with trastuzumab emtansine: primary results of the randomized, phase 3 study DESTINY-Breast02 |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Research 作者:Ian Krop; Yeon H. Park; Sung-Bae Kim; Giuliano Borges; Sercan Aksoy; et al 出版日期:2023 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)